Skip to main content
SpringerLink
Log in

Mitochondrial Dysfunction in Chronic Fatigue Syndrome

  • Chapter
Mitochondria in Pathogenesis

Conclusions

Understanding of mitochondrial dysfunction in CFS will clearly benefit from more study. Our findings warrant detailed studies on larger patient and control populations. The siting of mitochondrial impairment may lead to approaches for alleviating some of the symptoms of CFS. Studies on the effects of cytokines on cellular and mitochondrial bioenergetics are important to see whether cytokines or similar molecules are involved in linking CFS immune disturbances to mitochondrial dysfunction, and to better understand the consequences of cytokine therapies for cancer and viral infection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adamson, G. M., and Billings, R. E., 1992, Tumor necrosis factor induced oxidative stress in isolated mouse hepatocytes, Arch. Biochem. Biophys. 294:223–229.

    Article  CAS  PubMed  Google Scholar 

  • Aoki, T., Miyakoshi, H., Usuda, Y., and Hernerman, R. B., 1993, Low NK syndrome and its relationship to chronic fatigue syndrome, Clin. Immunol. Immunopath. 69:253–265.

    Article  CAS  Google Scholar 

  • Barbiroli, B., Montagna, P., Martinelli, P., Lodi, R., Lotti, S., Cortelli, P., Funicello, R., and Zaniol, P., 1993, Defectivebrainenergymetabolism by in vivo3lpmr spectroscopy in 28 patients with mitochondrial cytopathies, J. Cereb. Blood Flow Metab. 13:469–474.

    CAS  PubMed  Google Scholar 

  • Barke, R. A., Brady, P. S., and Brady, L. J., 1991, The Ca2+ second messenger system and interleukin-I-alpha modulation of hepatic gene transcription and mitochondrial fat oxidation, Surgery 110:285–294.

    CAS  PubMed  Google Scholar 

  • Behan, W. H. M., More, A.R., and Behan, P. O., 1991, Mitochondrial abnormalities in the postviral fatigue syndrome, Acta Neuropathol. 83:61–65.

    Article  CAS  PubMed  Google Scholar 

  • Bengtsson, A, and Henriksson, K. G., 1989, The muscle in fibromyalgia: A review of Swedish studies, J. Rheumatol. 16:144–149.

    Google Scholar 

  • Bock, G. R., and Whelan, J. (Eds.), 1993, Chronic Fatigue Syndrome, Ciba Foundation Symposium 173, Wiley, Chichester, England.

    Google Scholar 

  • Buchwald, D., 1991, Laboratory abnormalities in chronic fatigue syndrome, in PostViral Fatigue Syndrome (R. Jenkins and J. Mobray, Eds.), Wiley, Sussex, England, pp. 117–136.

    Google Scholar 

  • Buchwald, D., and Komaroff, A.L., 1991, Review of laboratory findings for patients withchronic fatigue syndrome, Rev. Infect. Dis. 13:S12–18.

    PubMed  Google Scholar 

  • Buchwald, D., Umali, P., Kith, P., Perlman, B. A., and Komaroff, A. L., 1995, Chronic fatigue and chronic fatigue syndrome: Prevalence in a Pacific Northwest health care system, Ann. Int. Med. 123:81–88.

    CAS  PubMed  Google Scholar 

  • Caligiuri, M., Murray, C., Buchwald, D., Levine, H., Cheney, P., Peterson D., Komaroff, A. L., and Ritz, J., 1987, Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome, J. Immunol. 139:3306–3313.

    CAS  PubMed  Google Scholar 

  • Cannon, J. G., Angel, J. B., Abad, L. W., Vannier, E., Mileno, M. D., Fagioli, L., Wolff, S. M., and Komaroff, A. L., 1997, Interleukin-1β interleukin-1 receptor antagonist, and soluble interleukin-lreceptor type II secretion in chronic fatigue syndrome, J. Clin. Immunol. 17:253–261.

    Article  CAS  PubMed  Google Scholar 

  • Carofoli, E., and Roman, I., (1980), Mitochondria and disease, Mol Aspects Med. 3:297–400.

    Google Scholar 

  • Chacon, E., Reece, J. M., Nieminen, A.-L., Zahrebelski, G., Herman, B., and Lemasters, J. J., 1994, Distribution of electrical potential, pH, free Ca2+, and volume inside cultured adult rabbit myocytes during chemical hypoxia: A multiparameter digitized confocal microscopic study, Biophys. J. 66:942–952.

    CAS  PubMed  Google Scholar 

  • Chazotte, B., and Pettengill, M., 1998, Cytokine effects on mitochondrial membrane potential and possible mitochondrial dysfunction in chronicfatigue and immune dysfunction syndrome, ASBMB J. May 1998.

    Google Scholar 

  • Chazotte, B., and Pettengill, M., 1999, Using membrane potential to follow cytokinc effects on mitochondria and possible dysfunction in chronic fatigue syndrome, Biophys. J. 76:A363.

    Google Scholar 

  • Chazotte, B., Loehr, J.P., and Hackenbrock, C.R., 1996, Quantitative analyses of membrane potential of mitochondria in individual living human cells related to chronic illness, FASEB J. 10:A1377.

    Google Scholar 

  • Cheney, P., and Lapp, C. W., 1992, The diagnosis of chronic fatigue syndrome: An assertive approach, CFIDS Chronicle Physician’s Forum, Sept. 13–19.

    Google Scholar 

  • Cho, W. K., and Stollerman, G. H., 1992, Chronic fatigue syndrome, Hospital Practice Sept 15 27:221–245.

    CAS  PubMed  Google Scholar 

  • Coates, P. M., Hale, D. E., Stanley, C. A., Corkey, B. E. and Cortner, J. A., 1985, Genetic deficiency of medium-chain Acyl-Co A dehyrogenase: Studies in cultured skin fibroblasts and peripheral mononuclear leukocytes, Pediat. Res. 19:671–676.

    CAS  PubMed  Google Scholar 

  • Dawson, D. M., and Sabin, T. D. (Eds.), Chronic Fatigue Syndrome, Little, Brown, Boston, 1993.

    Google Scholar 

  • Demitrack, M. A., 1994, Neuroendocrine aspects of chronic fatigue syndrome: Implications for diagnosis and research, in Chronic Fatigue Syndrome (S. E. Straus, Ed.), Marcel Dekker, New York.

    Google Scholar 

  • Demitrack, M. A., and Crofford, L. J., 1998, Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation infibromyalgia and chronic fatigue syndrome, Ann. NY Acad. Sci. 840:684–697.

    CAS  PubMed  Google Scholar 

  • DiMauro, S., Bonillia, E., Zeviani, M., Nakagawa, M., and DeVivo, D. C., 1985, Mitochondrial myopathies, Annu. Neurol. 17:521–538.

    CAS  Google Scholar 

  • Frackowiak, R. S. J., Herold, S., Petty, R. K. H., and Morgan-Hughes, J. A., 1988, The cerebral metabolism of glucose and oxygenmeasured withpositron tomography in patients withmitochondrialdiseases, Brain 111:1009–1024.

    PubMed  Google Scholar 

  • Fukuda, K., and Gantz, N. M., 1995, Management strategies for chronic fatigue syndrome, Fed. Pract. July.

    Google Scholar 

  • Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., and Komaroff, A., 1994, The chronic fatigue syndrome: A comprehensive approach to its definition and study, Ann. Intern. Med. 121:953–959.

    CAS  PubMed  Google Scholar 

  • Geng, Y.-j., Hansson, G. K., and Holme, E., 1992, Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells, Circ. Rex. 71:1268–1276.

    CAS  Google Scholar 

  • Grafman, J., Johnson, R., and Scheffers, M., 1991, Cognitive and mood-state changes in patients with chronic fatigue syndrome, Rev. Infect. Dis. 13:S45–S52.

    PubMed  Google Scholar 

  • Gunn, W. J., Connell, O. B., and Randell, B., 1993, Epidemiology of chronic fatigue syndrome: The Centers for Disease Control Study, in Chronic Fatigue Syndrome, (G. R. Bock and J. Whelan, Eds.), CIBA Foundation Symposium 173, Wiley, Chichester, England, pp. 83–108.

    Google Scholar 

  • Ho-Yen, D. O., Carrington, D., and Armstrong, A. A., 1988, Myalgic encephalomyelitis and alpha-interferon, Lancet i:125–127.

    Google Scholar 

  • Holms, G. P., Kaplan, J. E., Gantz, N. M., Komaroff, A. L., Schonberger, L. B., Straus, S. E., Jomes, J. F., Dubois, R. E., Cunningham-Rundles, C., Pahwa, S., Tosato, G., Zegans, L. S., Purtilo, D. T., Brown, N., Schooley, R. T., and Brus, 1., 1998, Chronic fatigue syndrome: A working case definition, Ann. Intern. Med. 108: 387–389.

    Google Scholar 

  • Hyde, B. M., and Jain, A., 1992, Clinical observations of CNS dysfunction in post-infectious, acute onset M.E./C.F.S., in The Clinical and Scientific Basis of Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (B. M. Hyde, J. A. Goldstein, P. H. Levine, Eds.), the Nightingale Foundation, Ottawa, Canada, pp. 38–57.

    Google Scholar 

  • Hyde, B. M., Goldstein, J. A., and Levine, P. H. (Eds.), The Clinical and Scientific Bash of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, The Nightingale Foundation, Ottawa, Canada.

    Google Scholar 

  • Gunn, W. J., Connell, D. B., and Randell, B., 1993, Epidemiology Chronic Fatigue Syndrome: The Centers for Disease Control Study In Chronic Fatigue Syndrome, (G. R. Bock and J. Whelan, eds.), Ciba Foundation Symposium’ 93. Wiley, Chichester, England.

    Google Scholar 

  • Jamal, G. A., and Hansen, S., 1985, Electrophysiological studies in the post-viral fatigue syndrome, J. Neurol, Neuorsurg. Psychiat. 48:691–694.

    CAS  Google Scholar 

  • Jenkins, R., and Mowbray, J. (Eds), 1991, Post-Viral Fatigue Syndrome, Wiley, Chichester, England.

    Google Scholar 

  • Jones, J. F., 1991, Serologic and immunologic responses in chronic fatigue syndrome with emphasis on the Epstein-Barr virus, Rev. Inject. Dis. 13:S26–S31.

    Google Scholar 

  • Kartounis, L. D., Troung, D. D., Morgan-Hughes, J. A., and Harding, A. E., 1992, The neuropsychological features of mitochondrial myopathies and encephalopathies, Arch. Neurol. 49:158–160.

    Google Scholar 

  • Klimas, N. G., Salvato, F. R., Morgan, R., and Fletcher, M. A., 1990, Immunologic abnormalities in chronic fatigue syndrome, J. Clin. Microbiol. 28:1403–1410.

    CAS  PubMed  Google Scholar 

  • Komaroff, A. L., 1997, A 56-year-old woman with chronic fatigue syndrome, JAMA 278:1179–1185.

    Article  CAS  PubMed  Google Scholar 

  • Komaroff, A. L., and Buchwald, D. S., 1998, Chronic fatigue syndrome: An update, Annu. Rev. Med. 49: 1–13.

    CAS  PubMed  Google Scholar 

  • Kruit, W. H., Punt, K. J., Goey, S. H., de Mulder, p. H., van Hoogenhuyze, D. C., Henzen-Logmans, W, and Stoter, G., 1994, Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon, Cancer 74:2850–2856.

    CAS  PubMed  Google Scholar 

  • Kuratsume, H., Yamaguti, K., Takahashi, M., Misaki, H., Tagawa, S., and Kitani, T., 1994, Acylcarnitine deficiency in chronic fatigue syndrome, Clin. Infect. Dis. 18:S62–S67.

    Google Scholar 

  • Lane, R. J. M., Burgess, A. P., Flint, J., Riccio, M., and Archard, L. C., 1995, Exercise responses and psychiatric disorder chronic fatigue syndrome, Brit. Med. J. 311:544–545.

    CAS  PubMed  Google Scholar 

  • Lane, R. J. M., Barrett, M. C., Taylor, D. J., Kemp, G. J., and Lodi, R., 1998a, Heterogeneity in chronic fatigue syndrome: Evidence from magnetic resonance spectroscopy of muscle, Neuromus. Disord. 8:204–209.

    CAS  Google Scholar 

  • Lane, R. J. M., Barrett, M. C., Woodrow, D., Moss, J., Fletcher, R., and Archard, L. C., 1998b, Muscle fibre characteristics and lactate responses to exercise in chronic fatigue syndrome, J. Neurol. Neurosurg. Psychiat. 64:362–367.

    CAS  PubMed  Google Scholar 

  • Lemasters, J. J., Chacon, E., Zahrebelski, G., Reece, J. M., and Nieminen, A.-L., 1993a, Laser scanning confocal microscopy of living cells, in Optical Microscopy: Emerging Methods and Applications (B. Herman and J. J. Lemasters, Eds), Plenum, New York, pp 339–354.

    Google Scholar 

  • Lemasters, J. J., Nieminen, A.-L., Chacon, E., Imberti, R., Gores, G. J., Reece, J. M., and Herman, B., 1993b, Use of fluorescent probes to monitor mitochondrial membrane potential in isolated mitochondria, cell suspensions, and cultured cells, in Mitochondrial Dysfunction Methods in Toxicology, Vol. 2 (L. H. Lash, and D. P. Jones, Eds.), Academic, New York, pp. 404–415.

    Google Scholar 

  • Lever, A. M. L., Lewis, D. M., Bannister, B. A., Fry, M., and Berry, N., 1988, Interferon production in postviral fatigue syndrome, Lancet ii:l01.

    Google Scholar 

  • Levy, J. A., 1994, Viral studies of chronic fatigue syndrome, Clin. Infect. Dis. 18:S117–S120.

    PubMed  Google Scholar 

  • Lloyd, A., Hickie, I., Brockman, A., Dwyer, J., and Wakefield, D., 1991, Cytokine levels in serum and cerebrospinal fluid in patients with chronic fatigue syndrome, J. Infect. Dis. 164:1023–1024.

    CAS  PubMed  Google Scholar 

  • MacDonald, E., 1987, Interferons as mediators of psychiatric morbidity; An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers, Lancer ii: 1175–1178.

    Google Scholar 

  • McCully, K. K.., Natelson, B. H., Lotti, S., Sisto, S., Leigh, J. S., 1996, Reduced oxidative metabolism in chronic fatigue syndrome, Muscle and Nerve 19:621–625.

    Article  CAS  PubMed  Google Scholar 

  • McGregor, N. R., Dunstan, R. H., Zerbes, M, Butt, H. L., Roberts, T. K., and Klineberg, I. J., 1996, Preliminary determination of a molecular basis to chronic fatigue syndrome, Biochem. Mol. Med. 57:73–80.

    Article  CAS  PubMed  Google Scholar 

  • Montague, T. J., Marrie, T. J., Klassen, G. A., Bewick, D. J., and Horacek, B. M,, 1989, Cardiac function at rest and with exercise in the chronic fatigue syndrome, Chest 95:779–784.

    CAS  PubMed  Google Scholar 

  • Nakagawa, K., Miller, F. N., Sims, D. E., Lentsch, A. B., Miyazaki, M., and Edwards, M. J., 1996, Mechanisms of interleukin-2 hepatic toxicity, Cancer Rex. 56:507–510.

    CAS  Google Scholar 

  • Natelson, B. H., Cohen, J. M., Brassloff, I., and Lee, H. J., 1993, A controlled study of brain magnetic resonance imaging in patients with the chronic fatigue syndrome. J. Neural. Sci. 120:203–207.

    Google Scholar 

  • Ojo-Amaze, H. A., Conley, E. J., and Peter, J. B., 1994, Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome, Clin. Infect. Dis. 18:S157–S159.

    Google Scholar 

  • Pawley J. B., Handbook of Biological Confocal Microscopy, 2nd ed., Plenum, New York, 1995.

    Google Scholar 

  • Peterson, P. L., 1995, The treatment of mitochondrial myopathies and encephalomyopathies, Biochim. Biophys. Acta 1271:275–280.

    CAS  PubMed  Google Scholar 

  • Petit, P. X., O’Conner, J. E., Grunwald, D., and Brown, S. C., 1990, Analysis of the membrane potential of rat-and mouse-liver mitochondria by flow cytometry and possible applications, Eur. J Biochem. 193:389–397.

    Google Scholar 

  • Plioplys, A. V, and Plioplys, S., 1997, Amantadine and L-carnitine treatment of chronic fatigue syndrome, Neuropsychobio. 35:16–23.

    CAS  Google Scholar 

  • Rasmussen, H., Nielsen, H., Andersen, V, Barington, T., Bendtzen, K.., Hansen, S., Nielsen, L., Pedersen, B. K.., and Wiik, A., 1994, Chronic fatigue syndrome: A controlled cross-sectional study, J. Rheumatol. 21:1527–1531.

    CAS  PubMed  Google Scholar 

  • Reyes, M., Gary, H. E., Jr., Dobbins, J. G., Randall, B., Steele, L., Fukuda, K.., Holms, G. P., Connell, D. G., Mawle, A. C., Schmid, D. S., Stewart, J. A., Schonberger, L. B., Gunn, W. J., and Reeves, W. C., 1997, Surveillance for chronic fatigue syndrome: Four U. S. cities, September 1989 through August 1993, MMWR 46:1–13.

    CAS  PubMed  Google Scholar 

  • Roe, C.R., and Coates, P. M., 1989, Acyl-CoA dehydrogenase deficiencies, in Metabolic Bases of Inherited Disease, 6th ed. (C. R., Scribner, A. L. Beaudet, W. A. Sly, and D. Valle Eds.), McGraw-Hill, NY, pp. 889–914.

    Google Scholar 

  • Rowe, P. C., Bou-Holaigah, I., Kan, J. S., and Calkins, H., 1995, Is neurally mediated hypotension an unrecognized cause of chronic fatigue? Lancet 345:623–624.

    CAS  PubMed  Google Scholar 

  • Sandman, C. A., Barron, J. L., Nackoul, K.., Goldstein, J., and Fidler, F., 1993, Memory deficits associated with chronic fatigue immune dysfunction syndrome, Biol. Psychiat, 33:618–623.

    CAS  PubMed  Google Scholar 

  • Schwartz, R. B., Garada, B. M., Komaroff, A. L., Tice, H. M., Gleit, M., Jolez, F. A., and Holman, B. L., 1993a, Detection of intracranial abnormalities in patients with chronic fatigue syndrome: Comparison of MR imaging and SPECT, Am. J. Rad. 162:935–941.

    Google Scholar 

  • Schwartz, R. B., Komaroff, A. L., Garada, B. M., Gleit, M., Doolittle, T. H., Bates, D. W., Vasile, R. G., and Holman, B. L., 1993b, SPECT imaging of the brain: Comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression, Am. J. Rad. 162:943–951.

    Google Scholar 

  • Straus, S. E., 1988, The chronic mononucleosis syndrome, J. Infect. Dis. 157:405–412.

    CAS  PubMed  Google Scholar 

  • Straus, S. E. (Ed.), 1994, Chronic Fatigue Syndrome, Marcel Dekker, New York.

    Google Scholar 

  • Vojdani, A., Ghoneum, M., Choppa, P. C., Magatoto, L., and Lapp, C. W., 1997, Elevatedapoptotic cell population in patients with chronic fatigue syndrome: The pivotal role of protein kinase RNA, J. Int. Med. 242:465–478.

    CAS  Google Scholar 

  • Wallace, D. A., 1992, Mitochondrial DNA diseases, Ann. Rev. Biochem. 61:1175–1212.

    CAS  PubMed  Google Scholar 

  • Wong, R., Lopaschuk, G., Zhu, G., Walker, D., Catellier, D., Burton D., Teo, K. Collins-Nakai, R., and Montague, T, 1992. Skeletal muscle metabolism in the chronic fatigue syndrome. Chest 102:1716–1722.

    CAS  PubMed  Google Scholar 

  • Zar, J. H., 1985, Biostatistical Analysis, 2nd ed., Prentice-Hall, Englewood Cliffs, New Jersey

    Google Scholar 

  • Zhang, C., Baumer, A., Mackay, I. R., Linnane, A. W., and Nagley, P., 1995, Unusual pattern of mitochondrial DNA deletions in skeletal muscle of an adult human with chronic fatigue syndrome, Hum. Mol. Genet. 4:751–754.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences, Campbell University, Buies Creek, North Carolina, 27506

    Brad Chazotte

Authors
  1. Brad Chazotte
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

    John J. Lemasters

  2. Case Western Reserve University, Cleveland, Ohio

    Anna-Liisa Nieminen

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Chazotte, B. (2002). Mitochondrial Dysfunction in Chronic Fatigue Syndrome. In: Lemasters, J.J., Nieminen, AL. (eds) Mitochondria in Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/0-306-46835-2_21

Download citation

  • DOI: https://doi.org/10.1007/0-306-46835-2_21

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46433-1

  • Online ISBN: 978-0-306-46835-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation